These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome. Iznardo H, Bredrup C, Bernal S, Gladkauskas T, Mascaró JM, Roé E, Baselga E. Am J Med Genet A; 2022 Apr; 188(4):1233-1238. PubMed ID: 34894066 [Abstract] [Full Text] [Related]
7. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib. Arts FA, Chand D, Pecquet C, Velghe AI, Constantinescu S, Hallberg B, Demoulin JB. Oncogene; 2016 Jun 23; 35(25):3239-48. PubMed ID: 26455322 [Abstract] [Full Text] [Related]
9. The Master of Puppets: Pleiotropy of PDGFRB and its Relationship to Multiple Diseases. Moura DAP, de Oliveira JRM. J Mol Neurosci; 2020 Dec 23; 70(12):2102-2106. PubMed ID: 32613555 [Abstract] [Full Text] [Related]
14. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis. Arts FA, Sciot R, Brichard B, Renard M, de Rocca Serra A, Dachy G, Noël LA, Velghe AI, Galant C, Debiec-Rychter M, Van Damme A, Vikkula M, Helaers R, Limaye N, Poirel HA, Demoulin JB. Hum Mol Genet; 2017 May 15; 26(10):1801-1810. PubMed ID: 28334876 [Abstract] [Full Text] [Related]
15. A novel de novo PDGFRB variant in a child with severe cerebral malformations, intracerebral calcifications, and infantile myofibromatosis. Guimier A, Gordon CT, Hully M, Blauwblomme T, Minard-Colin V, Bole-Feysot C, Nitschké P, Oufadem M, Boddaert N, Sarnacki S, Amiel J. Am J Med Genet A; 2019 Jul 15; 179(7):1304-1309. PubMed ID: 31004414 [Abstract] [Full Text] [Related]
16. A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib. Pond D, Arts FA, Mendelsohn NJ, Demoulin JB, Scharer G, Messinger Y. Genet Med; 2018 Jan 15; 20(1):142-150. PubMed ID: 28726812 [Abstract] [Full Text] [Related]
18. PDGF receptor mutations in human diseases. Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin JB. Cell Mol Life Sci; 2021 Apr 15; 78(8):3867-3881. PubMed ID: 33449152 [Abstract] [Full Text] [Related]
19. Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta. Takenouchi T, Okuno H, Kosaki K. Am J Med Genet C Semin Med Genet; 2019 Dec 15; 181(4):650-657. PubMed ID: 31710779 [Abstract] [Full Text] [Related]
20. Novel PDGFRB rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib. Hassan M, Butler E, Wilson R, Roy A, Zheng Y, Liem P, Rakheja D, Pavlick D, Young LL, Rosenzweig M, Erlich R, Ali SM, Leavey PJ, Parsons DW, Skapek SX, Laetsch TW. Cold Spring Harb Mol Case Stud; 2019 Oct 15; 5(5):. PubMed ID: 31645346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]